Beyond Treatment: Your Fertility Action Plan After Ovarian Cancer

A lot has already been written about what fertility preservation options exist for ovarian cancer patients. What gets talked about less is the how: the sequence, the decisions most women don’t know they need to make, and when they need to make them.

This guide, part of our “Beyond Treatment” series on ovarian cancer survivorship, provides a step-by-step action plan for navigating fertility and family planning across your ovarian cancer journey: before treatment, during it, and after. If you’ve already read our posts on fertility-sparing surgery, egg freezing (oocyte preservation), and the relationship between ovarian tumors and fertility, this is the piece that tells you what to do with all of that information. 

Step 1: Raise Fertility Before Your Treatment Plan Is Finalized, If You Still Can

Not after. Not once surgery is scheduled. Before.

One important caveat first, because it applies to a lot of women reading this: for many ovarian cancer patients, surgery comes before the diagnosis does. A mass gets found, it gets removed, and the pathology report is what finally names the disease. 

By then, one or both ovaries may already be gone. And because low-grade serous ovarian cancer is so often caught at an advanced stage, fertility preservation may be off the table entirely by the time anyone brings it up.

That is a real loss, and it deserves to be named rather than glossed over. If that’s where you are, skip ahead to Step 8. There are still paths to parenthood, and they’re covered there.

But if you have been diagnosed before losing your ovaries — through imaging, a biopsy, or a borderline tumor found early — this step is the one that matters most.

Raising fertility early is the step most patients miss. Not because they don’t care, but because they’re in shock and following the lead of their medical team. And according to ASCO fertility preservation guidelines, oncologists frequently don’t initiate these conversations before cancer-directed therapy begins. That means the responsibility often falls on you.

The window to act is shorter than most people realize. Egg and embryo freezing take approximately two to three weeks from ovarian stimulation to egg retrieval. That is often a workable delay, but only if you raise it immediately.

What to say: “Before we finalize the treatment plan, I want to discuss how it might affect my fertility and whether there’s time to preserve it.

Step 2: Get a Referral to a Reproductive Endocrinologist, Not Just Your Oncologist

Your oncologist is an expert in treating cancer. Fertility preservation is a separate specialty, and it requires a specialist: a reproductive endocrinologist (RE).

These two physicians need to be working in alignment before your first treatment begins. Your oncologist determines the medical urgency. Your RE determines what’s possible within that window. When they communicate early, more options stay on the table. When they don’t, options close.

Ask your oncologist directly for a referral to an RE, ideally within the same week as your diagnosis, if possible. Some reproductive medicine practices have expedited pathways specifically for cancer patients, and consultations can sometimes happen within 48 hours.

What to ask your oncologist: “Can you refer me to a reproductive endocrinologist before my treatment begins, and can you share my medical records with them so they understand my timeline?”

Learn more: “Ovarian Cancer Questions: From Diagnosis to Recovery — Essential Insights for Your Journey”

Step 3: Ask Directly Whether Fertility-Sparing Surgery Is an Option for Your Case

This isn’t a question every patient is eligible to ask. 

Fertility-sparing surgery (preserving the uterus and the unaffected ovary while removing only the cancerous tissue) is a viable approach for some early-stage diagnoses.

It’s most commonly considered for patients with borderline ovarian tumors (all subtypes, stage IA–IC), mucinous ovarian cancer at stage IA–IC, low-grade endometrioid and low-grade serous cancers at stage IA or IB, and germ cell and sex cord-stromal tumors. It is not recommended at any stage for clear cell ovarian cancer, high-grade serous, or high-grade endometrioid cancers, as the recurrence risk is simply too high.

For BOT patients specifically, research has cited pregnancy rates as high as 82.5% after conservative surgery: a figure worth knowing before you consent to a more radical procedure. But surgeons don’t always volunteer this option. 

What to ask your surgeon: “Is fertility-sparing surgery medically appropriate for my stage, grade, and tumor type? What are the tradeoffs?”

Step 4: Find Out Which Preservation Method Actually Fits Your Window

There isn’t one universal preservation path. The right option depends on your timeline, your diagnosis, and whether you have a partner or not. Here’s how to think about it:

• If you have 2–3 weeks before treatment begins: Egg or embryo freezing is typically the first option to explore. Embryo freezing has slightly higher success rates (live birth rates of 35–41%, vs. 26–32% for egg freezing), but requires sperm from a partner or donor.
• If treatment needs to start immediately: Ovarian tissue cryopreservation — surgically removing and freezing a portion of the ovary — doesn’t require a stimulation period. It’s now classified as an established (not experimental) method by ASCO.
• If you’re an LGSOC or BOT patient: Your treatment timeline and hormone therapy plan may affect which options are appropriate. This conversation needs to happen with both your oncologist and your RE.

The point isn’t to pick one option right now. The point is to understand which one your window actually allows for and to have that conversation with your RE before the window closes.

Step 5: Research Financial Assistance Before You Assume You Can’t Afford It

Fertility preservation is expensive. A single egg retrieval cycle can cost $10,000 or more before storage fees. That number stops a lot of women from even starting the conversation.

But there are resources that specifically exist for cancer patients, and they’re worth knowing about before you make any decisions based on cost alone:

• LIVESTRONG Fertility partners with fertility clinics to provide discounted or free services to cancer patients, along with free medication programs.
• The Chick Mission provides grants for fertility preservation specifically for young women with cancer diagnoses.
• Insurance coverage is expanding. As of this writing, 25 U.S. states and Washington D.C. have passed mandates requiring some insurance plans to cover medically indicated fertility preservation. Keep in mind that requirements vary widely in scope and eligibility criteria including age, marital status, and medical diagnosis.

Ask the fertility clinic’s financial coordinator (not just the billing department) about your specific options. Many clinics have navigators who help cancer patients access funding.

Step 6: Document Your Treatment: Every Drug, Dose, and Duration

This step is almost never on anyone’s radar during active treatment. But it will matter later.

If you work with a reproductive endocrinologist after treatment — whether to assess your remaining fertility, pursue preservation, or evaluate your chances of natural conception — they will want to know exactly what you were treated with. 

Specific chemotherapy drugs for ovarian cancer carry different levels of gonadotoxicity. The dose matters. The duration matters. And medical records can be incomplete, fragmented, or hard to obtain months or years later.

Keep a running log during treatment. Ask your oncology team for documentation at each appointment. Store it somewhere you can access easily.

What to track: Drug names, dosages, number of cycles, dates of treatment, and any radiation details including field location and dose.

Step 7: Ask Your Oncologist for a Clear Timeline on When It’s Safe to Try

The standard guidance is to wait at least six months after completing chemotherapy before attempting pregnancy, to allow time for potentially damaged eggs to clear. Many oncologists recommend waiting two to five years, since cancer recurrence risk is highest in the first two years after treatment, and a recurrence during pregnancy would be an extraordinarily difficult situation. The right wait time varies based on cancer type, stage, and treatment received.

The key is to ask for this timeline explicitly and to get it in writing. Not because the answer will be definitive: it may shift based on how your recovery goes, but because having a number gives you something to plan around instead of living in open-ended uncertainty.

What to ask: “Based on my diagnosis and treatment plan, what is your recommendation for how long I should wait before trying to conceive? And what would need to be true for that timeline to change?”

Then ask a second question that gets missed just as often: whether pregnancy itself is safe for your body after what you’ve been through.

Timing is only half the picture. Some chemotherapy drugs carry lasting effects that pregnancy can make worse. Cardiotoxic agents are the clearest example: pregnancy naturally increases cardiac output and strains the heart, so if you received a drug known to affect heart function, an echocardiogram before you try to conceive is a reasonable ask. The same logic applies to kidney function, lung function, and any lingering treatment side effects you’re still managing.

What else to ask: “Which of the drugs I received have long-term effects that pregnancy could worsen? Do I need cardiac, kidney, or other testing before trying to conceive?”

For more on what pregnancy looks like after a diagnosis, our post on ovarian cancer and pregnancy covers the full picture.

Step 8: Keep the Door Open in Both Directions

Two things are true that don’t always get said together.

First: ovarian reserve can recover. Post-treatment anti-Müllerian hormone (AMH) levels — a key measure of ovarian reserve — often increase for two to three years following treatment before gradually declining. For women who didn’t pursue preservation before treatment, that recovery window may create a second opportunity to explore it. It’s worth revisiting with your RE two years post-treatment, not writing it off.

Second: other paths to parenthood are real. Donor eggs, gestational surrogacy, adoption, and fostering are the routes many ovarian cancer survivors take to build their families. If the uterus was removed, surrogacy allows the use of frozen embryos or donor eggs. If eggs are no longer viable, donor eggs can be transferred to a preserved uterus. These options deserve genuine, early consideration as legitimate choices alongside biological pathways.

The emotional side of all this — the grief, the anger, the uncertainty — is real and it deserves space, too. Surgery-induced menopause can intensify those feelings for younger women. And connecting with others who understand the specific experience of LGSOC or BOT diagnosis, rather than ovarian cancer broadly, can make a significant difference.

Taking It One Step at a Time

The ovarian cancer journey doesn’t leave much room to breathe. The fertility decisions get layered on top of medical decisions, financial decisions, and emotional ones: all at once, often within days of a diagnosis.

But the steps above don’t all need to happen at the same time. Working through them, even imperfectly, even under pressure, gives you more agency over your future than waiting for someone else to bring it up.